30-Dec-2025
Globe Newswire (Tue, 30-Dec 4:25 PM ET)
Inovio Stock Sinks As FDA Pushes Back On Accelerated Approval For Rare Disease Drug
Benzinga (Mon, 29-Dec 11:59 AM ET)
TipRanks (Mon, 29-Dec 11:45 AM ET)
Inovio drops as respiratory papillomatosis asset denied accelerated review
Seeking Alpha News (Mon, 29-Dec 10:42 AM ET)
FDA Accepts Inovio’s BLA for INO-3107 Review
TipRanks (Mon, 29-Dec 8:47 AM ET)
PRNewswire (Mon, 29-Dec 8:05 AM ET)
INOVIO Reports Inducement Grant Under Inducement Plan
PRNewswire (Fri, 19-Dec 4:05 PM ET)
INOVIO to Participate in December Investor Conferences
PRNewswire (Tue, 18-Nov 8:05 AM ET)
INOVIO Announces Pricing of $25 Million Public Offering
PRNewswire (Tue, 11-Nov 8:40 AM ET)
INOVIO Announces Proposed Public Offering
PRNewswire (Mon, 10-Nov 6:10 PM ET)
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Inovio Pharmaceuticals trades on the NASDAQ stock market under the symbol INO.
As of December 30, 2025, INO stock price climbed to $1.76 with 2,270,135 million shares trading.
INO has a beta of 1.12, meaning it tends to be more sensitive to market movements. INO has a correlation of 0.06 to the broad based SPY ETF.
INO has a market cap of $120.92 million. This is considered a Micro Cap stock.
Last quarter Inovio Pharmaceuticals reported $0 in Revenue and -$.44 earnings per share. This fell short of revenue expectation by $-8,330 and exceeded earnings estimates by $.05.
In the last 3 years, INO traded as high as $23.88 and as low as $1.30.
The top ETF exchange traded funds that INO belongs to (by Net Assets): VTI, VXF, IWC, MSSM.
INO has underperformed the market in the last year with a price return of -5.9% while the SPY ETF gained +16.7%. INO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -27.9% and -22.1%, respectively, while the SPY returned +3.8% and +1.2%, respectively.
INO support price is $1.63 and resistance is $1.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INO shares will trade within this expected range on the day.
